Carregant...
Long-Term Comparative Effectiveness of Endeavor Zotarolimus-Eluting and Everolimus-Eluting Stents in New York
BACKGROUND: Endeavor zotarolimus-eluting stents (E-ZES) and everolimus-eluting stents (EES) as second-generation stents were approved for use in percutaneous coronary interventions (PCIs) in 2008. We aimed to evaluate the long-term outcomes of E-ZES vs EES using New York State (NYS) cardiac registri...
Guardat en:
| Publicat a: | Int J Cardiol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5490976/ https://ncbi.nlm.nih.gov/pubmed/28389121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcard.2017.03.095 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|